| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.0092 | 1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.0067 | 1 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.00087 | 1 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.00069 | 1 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.00092 | 1 |